EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Programmed ventricular stimulation for risk stratification in symptomatic athletes with nonischemic left ventricular scar and preserved ejection fraction

Luigi Sciarra iD, Fabrizio Ricci iD, Elena Cavarretta iD, Zefferino Palamà iD, Alessio Borrelli iD, Mauro Di Roma, Leonardo Pignalosa iD, Federico Zanin iD, Daniele Falco, Giulia Renda iD, Cesare Mantini iD, Sabina Gallina und 3 weitere

Europace · 2026

DOI: 10.1093/europace/euag160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Europace, 2026. Verfasst von Luigi Sciarra und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life, Health and Environmental Sciences (MeSVA), University of L'Aquila, Piazzale Salvatore Tommasi 1, 67100 L'Aquila, Italy. Hauptthemen laut MEDLINE: Stroke Volume, Athletes, Ventricular Function, Left, Cicatrix. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Non-ischaemic left ventricular (LV) scar is increasingly recognized in athletes with preserved left ventricular ejection fraction (LVEF) and may represent a substrate for malignant ventricular arrhythmias. The role of electrophysiological study (EPS) with programmed ventricular stimulation (PVS) for risk stratification in this population remains unclear. This study aimed to evaluate the prognostic value of inducibility at EPS in symptomatic athletes with non-ischaemic LV scar and preserved LVEF. Methods and results We prospectively enrolled 72 consecutive athletes (mean age 48.9 ± 13.1 years; 66.7% male) with documented non-ischaemic LV scar, preserved LVEF (≥50%), and arrhythmic symptoms (tachycardic palpitations, syncope/presyncope, and/or exercise-related ventricular arrhythmias) undergoing EPS. Inducibility was defined as sustained ventricular arrhythmias during PVS. The primary endpoint was the occurrence of major arrhythmic events (MAE), including sudden cardiac death, sustained ventricular tachycardia/ventricular fibrillation, or appropriate implantable cardioverter-defibrillator therapy. Twenty-three athletes (31.9%) were inducible (EPS+), while 49 (68.1%) were non-inducible (EPS−). Baseline characteristics were largely comparable between groups, although QRS duration was longer in inducible athletes (104.6 ± 15.2 ms vs. 95.5 ± 14.3 ms; P = 0.019). Twenty-three inducible athletes underwent ICD implantation (18 transvenous and 5 subcutaneous devices), whereas 16 non-inducible athletes received an implantable loop recorder. During a median follow-up of 42 months, 11 major arrhythmic events occurred. Nine events occurred among inducible athletes and consisted of sustained ventricular arrhythmias (monomorphic VT, polymorphic VT, or ventricular fibrillation) successfully terminated by appropriate ICD therapy, whereas two major arrhythmic events occurred among non-inducible athletes and required successful resuscitation followed by ICD implantation. No arrhythmic deaths occurred during follow-up. Event-free survival at 50 months was 40.6% in inducible athletes and 95.9% in non-inducible athletes (log-rank P < 0.001).

Conclusion

In symptomatic athletes with non-ischaemic LV scar and preserved LVEF, inducibility at EPS identifies a subgroup at higher risk of MAE, whereas non-inducibility is associated with a low event rate. EPS may represent a useful adjunctive tool for arrhythmic risk stratification in athletes, particularly in those without conventional high-risk features.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stroke VolumeAthletesVentricular Function, LeftCicatrixElectrophysiologic Techniques, CardiacArrhythmias, CardiacTachycardia, VentricularHeart VentriclesHumansMaleMiddle AgedRisk AssessmentProspective StudiesFemaleRisk FactorsAdultDeath, Sudden, CardiacPredictive Value of TestsDefibrillators, ImplantableElectric Countershock

Stichwörter der Autor:innen

Electrophysiological studyNonischemic myocardial scarPreserved ejection fractionProgrammed ventricular stimulationRisk stratificationVentricular arrhythmias

Autor:innen und Institutionen

  • Department of Life, Health and Environmental Sciences (MeSVA), University of L'Aquila, Piazzale Salvatore Tommasi 1, 67100 L'Aquila, Italy.
  • Department of Neuroscience, Imaging and Clinical Sciences, G. D'Annunzio University of Chieti-Pescara, Chieti 66100, Italy.
  • Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina 04100, Italy.
  • Department of Cardiology, Casa di Cura Villa Verde, Taranto 74121, Italy.
  • Cardiology Unit, GVM Care and Research, San Carlo di Nancy Hospital, Rome 00100, Italy.
  • Department of Radiology, Aurelia Hospital, Rome 00100, Italy.

ORCID-Profile: Luigi Sciarra, Fabrizio Ricci, Elena Cavarretta, Zefferino Palamà, Alessio Borrelli, Leonardo Pignalosa, Federico Zanin, Giulia Renda, Cesare Mantini, Francesco Brancati, Antonio Scarà

Zitieren

APA

Sciarra, L., Ricci, F., Cavarretta, E., Palamà, Z., Borrelli, A., Di Roma, M., Pignalosa, L., Zanin, F., Falco, D., Renda, G., Mantini, C., Gallina, S., Brancati, F., Romano, S., & Scarà, A. (2026). Programmed ventricular stimulation for risk stratification in symptomatic athletes with nonischemic left ventricular scar and preserved ejection fraction. Europace. https://doi.org/10.1093/europace/euag160

Vancouver

Sciarra L, Ricci F, Cavarretta E, Palamà Z, Borrelli A, Di Roma M, et al. Programmed ventricular stimulation for risk stratification in symptomatic athletes with nonischemic left ventricular scar and preserved ejection fraction. Europace. 2026. doi:10.1093/europace/euag160

BibTeX
@article{Sciarra2026,
  author = {Sciarra, Luigi and Ricci, Fabrizio and Cavarretta, Elena and Palamà, Zefferino and Borrelli, Alessio and Di Roma, Mauro and Pignalosa, Leonardo and Zanin, Federico and Falco, Daniele and Renda, Giulia and Mantini, Cesare and Gallina, Sabina and Brancati, Francesco and Romano, Silvio and Scarà, Antonio},
  title = {Programmed ventricular stimulation for risk stratification in symptomatic athletes with nonischemic left ventricular scar and preserved ejection fraction},
  journal = {Europace},
  year = {2026},
  doi = {10.1093/europace/euag160}
}
Kostenlos starten →